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ABSTRACT
The region surrounding the central canal (CC) of the spinal cord is a highly plastic area, deﬁned as
a postnatal neurogenic niche. Within this region are ependymal cells that can proliferate and dif-
ferentiate to form new astrocytes and oligodendrocytes following injury and cerebrospinal ﬂuid
contacting cells (CSFcCs). The speciﬁc environmental conditions, including the modulation by neu-
rotransmitters that inﬂuence these cells and their ability to proliferate, are unknown. Here, we
show that acetylcholine promotes the proliferation of ependymal cells in mice under both in vitro
and in vivo conditions. Using whole cell patch clamp in acute spinal cord slices, acetylcholine
directly depolarized ependymal cells and CSFcCs. Antagonism by speciﬁc nicotinic acetylcholine
receptor (nAChR) antagonists or potentiation by the a7 containing nAChR (a7*nAChR) modulator
PNU 120596 revealed that both a7*nAChRs and non-a7*nAChRs mediated the cholinergic
responses. Using the nucleoside analogue EdU (5-ethynyl-2’-deoxyuridine) as a marker of cell pro-
liferation, application of a7*nAChR modulators in spinal cord cultures or in vivo induced prolifera-
tion in the CC region, producing Sox-2 expressing ependymal cells. Proliferation also increased in
the white and grey matter. PNU 120596 administration also increased the proportion of cells coex-
pressing oligodendrocyte markers. Thus, variation in the availability of acetylcholine can modulate
the rate of proliferation of cells in the ependymal cell layer and white and grey matter through
a7*nAChRs. This study highlights the need for further investigation into how neurotransmitters
regulate the response of the spinal cord to injury or during aging. STEM CELLS 2015;33:2864–2876
SIGNIFICANCE STATEMENT
Our work has shown that by, activating a specific neurotransmitter receptor, we can transform a
population of spinal cord cells, the ependymal cells from being a quiescent stem cell population
into one that can proliferate and thus enable spinal cord plasticity. Our findings are therefore of
wide scientific interest to those involved in understanding adult neurogenesis and spinal cord
function in health and disease. Perhaps most critically, these data will be of interest to those who
are seeking to understand how we can harness the body’s natural ability to trigger cell prolifera-
tion and differentiation or even to suppress inappropriate proliferative responses.
INTRODUCTION
In the mammalian spinal cord, the area sur-
rounding the central canal (CC) exhibits plastic-
ity. First, ependymal cells display neural stem
cell features in vitro as they are capable of neu-
rosphere formation, self-renewal and differen-
tiation into the three neural lineages [1, 2]. In
vivo, spinal cord ependymal cells can proliferate
under both normal and injured conditions and
differentiate into astrocytes and oligodendro-
cytes following injury [3–5] and into neurons in
a model of multiple sclerosis [6].
Second, there is a population of cells found
either in the subependymal layer or inter-
spersed with ependymal cells which possess a
large cerebrospinal ﬂuid-contacting process;
thus, they are known as cerebrospinal ﬂuid con-
tacting cells (CSFcCs). CSFcCs express immuno-
histochemical markers of immature neurons or
neurons involved in plasticity, such as Double-
cortin, PSA-NCAM (polysialylated neuronal cell
adhesion molecule) and growth-associated pro-
tein 43 [7, 8] and display electrophysiological
properties consistent with them being neurons
at different stages of maturity [7]. Their prolifer-
ative capability is less well understood.
Considering the stem cell potential of epen-
dymal cells, understanding physiological factors
inﬂuencing their function and manipulating
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their proliferation rate could provide an avenue to replenish
spinal cord cellular pools that are depleted by injury or disease.
Such a physiological factor, endogenous dopamine, promotes
the generation of spinal motor neurons in lesioned adult zebra-
ﬁsh spinal cord [9].
Spinal cord regeneration in mammals is less successful and
the inﬂuence of neurotransmitters is unknown; therefore, we
determined whether CSFcCs and/or ependymal cells were
modulated by neurotransmitters, with a focus on acetylcholine
(ACh). Neurotransmitters, including ACh, can regulate prolifera-
tion, neuronal differentiation and maturation in established
areas of mammalian postnatal neurogenesis such as the sub-
ventricular zone of the forebrain and the subgranular zone in
the hippocampal dentate gyrus [10]. For example, reducing cho-
linergic inputs to the olfactory bulb decreases numbers of
newly born neurons [11], while their survival was improved by
enhancing cholinergic signaling using the centrally acting revers-
ible acetylcholinesterase inhibitor, donepezil [12]. In the den-
tate gyrus, newborn cells receive cholinergic inputs [13] and
the normal survival, maturation, and integration of adult-born
neurons is reliant on functional a7-containing nicotinic acetyl-
choline receptors (a7*nAChRs [14]). In the subventricular zone,
cholinergic neurons have recently been identiﬁed that enhance
neural stem cell proliferation, thus cholinergic circuits may be
critical during numerous stages of postnatal neurogenesis [15].
Cholinergic interneurons reside in the CC region of the spinal
cord [16, 17] and thus are well placed to inﬂuence cells in the
neurogenic niche.
Given the inﬂuence of ACh on cells in other postnatal
neurogenic niches and the neural stem cell potential of epen-
dymal cells, we hypothesized that these cells are inﬂuenced
by activation of cholinergic receptors which modulate their
proliferative capacity. We use electrophysiology in an in vitro
spinal cord slice preparation to demonstrate that both epen-
dymal cells and CSFcCs respond to ACh. Furthermore, applica-
tions of a cholinergic modulator in vitro to organotypic slice
cultures and in vivo combined with 5-ethynyl-2’-deoxyuridine
(EdU) labeling reveal that cholinergic stimulation enhances
the proliferation of ependymal cells, but not CSFcCs.
MATERIALS AND METHODS
Full details are given in Supporting Information.
Animals
Wistar rats (P9-adult) or C57/Bl6 mice (P9-adult) of either sex
were used in line with the UK Animals (Scientiﬁc Procedures)
Act 1986 and ethical standards set out by the University of
Leeds Ethical Review Committee. Every effort was made to
minimize the number of animals used and their suffering.
Slice Preparation
Animals (9–28 days) were anaesthetized with sodium pento-
barbitone (60 mg/kg) I.P and perfused transcardially with ice-
cold sucrose artiﬁcial CSF (aCSF) before cutting 300 mm thick
transverse spinal cord slices using a vibrating microtome.
Whole Cell Patch Clamp Electrophysiology
Whole cell current clamp recordings were made at room tem-
perature from CSFcCs and ependymal cells. Neurobiotin (0.5
%; Vector Laboratories, Peterborough, UK, https://www.vec-
torlabs.com/uk/) and tetramethylrodamine (0.02 %; Life Tech-
nologies, Paisley, UK, https://www.lifetechnologies.com/uk/en/
home.html) were added to visualize the cells post-recording
(see ref. 18).
ACh (3–10 mM) was pressure ejected locally; cholinergic
antagonists were bath applied at a ﬂow rate of approximately 4–
6 ml/minute: these were the muscarinic antagonist atropine (5
mM, Sigma, Gillingham, UK, https://www.sigmaaldrich.com/
united-kingdom.html), the nonselective nAChR antagonist, meca-
mylamine (MCA; 50 mM), the selective a7*nAChR antagonist at
low nanomolar concentrations, methyllycaconitine (MLA;
20 nM), the non-a7*nAChR antagonist at low micromolar con-
centrations, dihydro-b-erythroidinne (DHbE; 1 mM), and the spe-
ciﬁc a7*nAChR positive allosteric modulator, PNU 120596 (10
mM; AbCam Biochemicals, Cambridge UK, http://www.abcam.
com/). In some experiments, the following drugs were added to
the aCSF: tetrodotoxin (TTX; 1 mM; Sigma) to block voltage-gated
Na1 channels, D-(-)22-amino-5-phosphonopentanoic acid (D-
AP5; 50 mM) to block NMDA receptors, and 2,3-dioxo-6-nitro-
1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; 20
mM) to block AMPA receptors. Unless stated, drugs were
obtained from Tocris Bristol, UK, http://www.tocris.com/.
Organotypic Spinal Cord Culture
C57/Bl6 mice (9–14 days) were anaesthetized with sodium
pentobarbitone (60 mg/kg; intraperitoneal [I.P.]), perfused
transcardially with sucrose aCSF and the thoracolumbar spinal
cord was removed and transverse sections cut at 300 mm
using a McIlwain tissue chopper. After 48 hours in culture, 1
mM EdU (Invitrogen, Paisley, UK) was added into the medium.
PNU 120596 (1 mM), MLA (20 nM) alone or a combination of
the two was added to the medium of some slices, while
some slices from the same animal were untreated (controls)
and the slices were maintained in culture for a further 120
hours.
In Vivo Application of Cholinergic Drugs
Mice (age 6–8 weeks) were injected intraperitoneally with
EdU (0.1 ml at 10 mM) and either PNU 120596 (0.1 ml; 10
mM, number of animals5 7) or saline (0.1 ml, number of ani-
mals5 7) daily for a period of 4 days.
Preparation of Tissue for EdU Detection and
Immunohistochemistry
Rats (250 g) or mice used above were anaesthetized with
sodium pentobarbitone (60 mg/kg) I.P. and perfused transcar-
dially with 4% paraformaldehyde (PFA). Thoracic (T4–8) and
lumbar (L1–4) spinal cord sections of 50 mm were cut on a
vibrating microtome. For cultured tissue, slices were ﬁxed in
4% PFA for 4–7 hours at 48C.
EdU Localization
For EdU detection in cultures, slices (protected from light)
were incubated in 320 ml distilled water, 25 ml 2 M Tris buffer,
50 ml 10 mM copper sulphate, 5 ml Azide594, and 100 ml
0.5 M ascorbic acid for 30 minutes, then washed in Tris buffer
(2 3 10 min). For EdU detection in sections, the same proto-
col was followed except 5 ml biotinylated azide (1 mM) was
used instead of Azide594. This was detected by incubating
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sections in Streptavidin Alexa555 (1:1,000 in PBS1 0.1% Triton,
Invitrogen) for 1 hour.
Immunohistochemistry
Immunoﬂuorescence was performed with antibodies against
choline acetyl transferase (ChAT; goat, 1:500; Millipore, Watford,
UK, http://www.merckmillipore.com/GB/), cluster of differentia-
tion 24 (CD-24; rat, 1:500; BD, Biosciences, Oxford UK, http://
www.bdbiosciences.com/eu/home), polycystic kidney disease 2-
like 1 (PKD2L1, 1:1,000; rabbit, Abcam, Biochemicals), PanQKI
(mouse, UC Davis/NIH Neuromab Facility, Davis, CA, http://neu-
romab.ucdavis.edu/, N147/6, 1:2), glial ﬁbrillary acidic protein
(GFAP, mouse, UC Davis/NIH Neuromab Facility N206A/8 1:100),
a1 Na1/K1 ATPase (NKAa1;rabbit, Epitomics, Burlingame, CA,
http://www.epitomics.com/, 1:1,000), (beta tubulin III (Tuj1,
chicken, 1:500 Neuromics, Edina, MN, http://www.neuromics.
com/antibodies), Sox2 (goat, 1:1,000 Santa-Cruz), and NeuN
(mouse, Millipore, 1:1,000). Antibodies were detected with
appropriate Alexa488 conjugated secondary antibodies.
Image Capture and Manipulation
Sections were imaged using a Zeiss LSM510 Meta laser scan-
ning confocal microscope equipped with argon (kex5 488 nm)
and He-Ne (kex5 543 nm) lasers. Images were captured using
Carl Zeiss ZEN software and images adjusted for brightness,
contrast, and intensity using CorelDraw16 software. Figures are
single plane confocal images.
Analysis of Data
For electrophysiology, changes in membrane potential were
recorded following ACh application and all data expressed as
mean6 SE. Drug effects were determined using paired t-tests.
When the CSFcCs were separated into different subtypes, one-
way analysis of variance (ANOVA) with post hoc Bonferroni tests
were used to determine the effects of ACh and two-way
ANOVAs with post hoc Bonferroni tests to determine effects of
cholinergic modulators on the ACh responses (n5 no. of cells).
EdU-positive cells and cells also immunopositive for the
speciﬁc antibodies were counted in the white and grey matter
and the CC region (within 10 mm of the abluminal edge of the
ependymal cells) directly through visualization down a micro-
scope (340 magniﬁcation). Cells were mapped, counted, and
checked by two investigators. Counts are given as mean num-
ber of EdU-positive cells per 300 mm slice in cultured slices or
per 50 mm section for in vivo treatment (n5 no. of slices or sec-
tions, N5 no. of animals). All data are expressed as means6 SE
and for statistical analysis, one-way ANOVAs with post hoc Bon-
ferroni tests determined differences in the numbers of prolifer-
ating cells between control and PNU treated slices and
percentages of colocalization.
Figure 1. Cholinergic structures are found in close apposition to ependymal cells and cerebrospinal ﬂuid contacting cells (CSFcCs). (A):
Immunohistochemistry for the CSFcC marker PKD2L-1 (red) and the ependymal cell marker CD24 (green). (B): Combined immunohisto-
chemistry for choline acetyltransferase (ChAT, red) and CD24 (green). (C): Combined immunohistochemistry for ChAT (red) and PKD2L1
(green). Scale bars5 10 mm. (Ai, Bi, Ci): Higher magniﬁcation views of the areas boxed in (A, B, C), respectively. Scale bars5 5 mm.
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Figure 2. Acetylcholine has profound depolarizing effects on ependymal cells and cerebrospinal ﬂuid contacting cell (CSFcCs). (A–D):
Responses of ependymal cells and CSFcCs to depolarizing and hyperpolarizing current pulses (A and B,6 100 pA; C and D,1 10 to 230
pA). Arrows denote synaptic potentials. These responses, together with the morphology of the cells that had been ﬁlled with neurobio-
tin (Ai-Ci) and rhodamine (Di), were used for identiﬁcation of cell types. Scale bars5 10 mm. (Aii–Dii): Responses of cells to pressure
application of acetylcholine (ACh); arrows denote puff applied. (E): Overlay of the responses to ACh in different cells to show the differ-
ence in amplitude of the depolarization. (F): Responses to ACh recorded in the presence (tetrodotoxin [TTX]) and absence (control) of
TTX. Abbreviations: ACh, acetylcholine; CSFcC, cerebrospinal ﬂuid contacting cell; TTX, tetrodotoxin.
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RESULTS
Cholinergic Structures Closely Appose Both Ependymal
Cells and CSFcCs
ChAT immunopositive structures were closely apposed to
ependymal cells identiﬁed as CD24 1ve [19] (Fig. 1A, 1B) and
CSFcCs as PKD2L1 1ve [20] (Fig. 1A, 1C), indicating that cho-
linergic terminals are ideally located to inﬂuence both cell
types in this CC region.
Ependymal Cells and CSFcCs Are Acutely Depolarized
by Activation of Cholinergic Receptors
Ependymal cells and CSFcCs were distinguished by their volt-
age responses to current injections and the morphology
revealed by intracellular dye-loading. Whole cell patch clamp
recordings in acute spinal cord slices revealed that ependymal
cells had a low input resistance (IR, 96.36 12.6 MX, n5 79
cells) and no spontaneous activity (Fig. 2A). Ependymal cells
also exhibited gap junction coupling between cells, illustrated
by transfer of neurobiotin into neighbouring cells, as expected
from previous studies [18]. Dye ﬁlling conﬁrmed ependymal
cells by a lack of process into the CC (Fig. 2Ai). CSFcCs were
categorized into three subtypes: subtype 1 cells were deﬁned
by passive responses to current injections, no spontaneous
activity and a small IR (66 6 9 MX; n5 14 cells; Fig. 2B). Sub-
type 2 cells produced an action potential at the beginning of
the positive current injection, exhibited spontaneous activity
in the form of synaptic potentials that could be blocked by
TTX (not shown) as seen previously [7] and had a large IR
(26686 130 MX; n5 130 cells; Fig. 2C). Subtype 3 cells could
produce multiple action potentials in response to positive cur-
rent pulses (Fig. 2D). These cells also exhibited spontaneous
activity and an average IR (23366 149 MX; n5 52 cells) that
was not signiﬁcantly different from that of subtype 2 CSFcCs.
Cells were conﬁrmed as CSFcCs post-recording by the pres-
ence of a process into the CC (Fig. 2Bi–2Di).
Pressure ejection of ACh (3 mM) depolarized 100% of
CSFcCs (n5 82 cells) and ependymal cells (n5 36 cells; Fig.
2Aii–2Dii). The responses of each cell type to ACh varied in
amplitude for ependymal cells (3.06 0.3 mV; n5 36), subtype
1 CSFcCs (2.26 0.2 mV; n5 17 cells), subtype 2 CSFcCs (18.9
6 1.2 mV; n5 46 cells), and subtype 3 CSFcCs (26.26 2.2
mV; n5 19 cells). A one-way ANOVA revealed signiﬁcant dif-
ferences in the amplitude of the cholinergic response of epen-
dymal cells, subtype 1 CSFcCs, subtype 2 CSFcCs, and subtype
3 CSFcCs (p< 0.001). Post hoc tests revealed no signiﬁcant
difference between the amplitude of the cholinergic response
in ependymal cells and subtype 1 CSFcCs (p5 1); however,
the amplitudes of these responses were signiﬁcantly smaller
than those of both subtype 2 and subtype 3 CSFcCs
(p< 0.001; Fig. 2E). The response to ACh was likely to be a
direct effect on ependymal cells and CSFcCs as the responses
were not signiﬁcantly decreased in the presence of TTX, AP5,
and NBQX (p< 0.05; n5 3–5 cells; Fig. 2F).
Cholinergic Responses of Ependymal Cells and CSFcCs
Are Mediated by nAChRs
Atropine (5 mM), the muscarinic selective antagonist, had no
signiﬁcant effect on ACh responses in either cell type (regard-
less of CSFcC subtype; Fig. 3A). The nicotinic-selective antago-
nist, MCA (50 mM), signiﬁcantly reduced the ACh response in
both ependymal cells (2.96 0.9 mV to 0.26 0.1 mV; n5 6
cells; p< 0.05) and all CSFcCs, regardless of subtype
(17.96 2.3 mV to 1.16 0.5 mV; p< 0.001; n5 6 cells;
Fig. 3B).
DHbE, a selective non-a7*nAChR antagonist at the con-
centration used (1 lM), decreased the response of both
ependymal cells (3.76 0.7 mV to 1.96 0.4 mV; n5 9 cells)
and CSFcCs (16.16 1.8 mV to 3.06 0.5 mV; n5 20 cells, Fig.
3C). Separating the CSFcCs into the deﬁned subtypes revealed
that there was a differential effect of DHbE on the speciﬁc
subtypes. The ACh response (expressed as a percentage of
the control response) in the presence of DHbE was 52%6 4%
(n5 3 cells) for subtype 1, 22%6 3% (n5 11 cells) for sub-
type 2 and 9%6 4% (n5 6 cells) for subtype 3. This degree of
antagonism by DHbE was signiﬁcantly different for each sub-
type (p< 0.05, Fig. 3D).
The contribution of a7*nAChRs was investigated using
MLA, which is a selective a7*nAChR antagonist at the concen-
tration used (20 nM, [21]). Bath application of MLA signiﬁ-
cantly decreased the amplitude of the cholinergic response in
ependymal cells from 4.16 0.8 mV to 3.56 0.8 mV (n5 6
cells; p< 0.05). The amplitude of the cholinergic response in
CSFcCs was also signiﬁcantly decreased in MLA from
24.26 3.6 mV to 19.76 3.4 mV (n5 8 cells; p< 0.05).
All ACh responses remaining in the presence of DHbE
could also be profoundly potentiated by the selective
a7*nAChR modulator, PNU 120596 (10 lM), regardless of cell
type. A signiﬁcant increase in the amplitude of the cholinergic
response of ependymal cells (1.56 0.2 mV to 7.36 1.9 mV;
n5 4 cells; p< 0.05) and all CSFcCs, regardless of subtype
(3.66 0.7 mV to 27.66 4.0 mV; n5 10 cells; p< 0.001) was
observed in the presence of PNU 120596 (Fig. 3E). This poten-
tiation could be completely antagonized by MLA, with
responses in DHbE, PNU 120596, and MLA not signiﬁcantly
different from those observed in the presence of DHbE alone
(82%6 20%; n5 4 cells; p5 0.39, Fig. 3E).
Activation of a7*nAChRs Increases Proliferation of
Ependymal Cells in Cultured Spinal Cord Slices
The possibility that a7*nAChR modulation could inﬂuence cell
proliferation in the spinal cord was tested by the addition of
PNU 120596 (1 mM) to the culture medium in organotypic
spinal cord slice cultures. The numbers of EdU-positive cells
around the CC in PNU 120596 treated slices were signiﬁcantly
higher (137.56 13.5; n5 13 slices, N5 6 animals) than those
in saline treated control slices (76.26 4.9; n5 16 slices, N5 6
animals; p< 0.001); (Fig. 4A, 4B). Addition of PNU 120596 in
the presence of the a7*nAChR antagonist MLA (20 nM) signif-
icantly reduced the number of EdU-positive cells (51.66 5.6;
n5 14 slices, N5 6 animals; p< 0.0001) compared with those
observed in the presence of PNU 120596 alone. Indeed, the
number of EdU-positive cells in PNU 120596 and MLA was
not signiﬁcantly different to those observed in the saline con-
trol. To test whether a7*nAChRs were being endogenously
activated in the spinal cord cultured slice, MLA alone was
applied, which signiﬁcantly reduced cell proliferation com-
pared with control (Fig. 4A). This indicates that activation of
these cholinergic receptors contributes to endogenous levels
of proliferation.
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Activation of a7*nAChRs Increases Proliferation of
Ependymal Cells In Vivo
To determine whether the a7*nAChR-mediated enhancement
of proliferation in slice culture could be extended to the
whole animal and could also be observed in adults, the
effects of in vivo application of the selective a7*nAChR modu-
lator PNU 120596 on cell proliferation in the CC, grey, and
white matter of the spinal cord were tested. Sections were
Figure 3. Both a7*nAChRs and non-a7*nAChRs contribute to the depolarizations. (A): Acetylcholine (Ach) responses of cerebrospinal ﬂuid
contacting cells (CSFcCs) or ependymal cells in the presence and absence (labeled control) of the muscarinic receptor antagonist, atropine
(5 mM). (B): ACh responses of CSFcCs or ependymal cells in the presence and absence (labeled control) of the nonselective nicotinic recep-
tor antagonist, mecamylamine (50 mM). (C): ACh responses of ependymal cells and CSFcC subtypes in the presence and absence of dihydro-
b-erythroidinne (DHbE) (1 mM) (D): Mean amplitude6 SE of the response to ACh during the bath application of DHbE expressed as a per-
centage of the initial response to ACh, for ependymal cells, CSFcCs and CSFcC subtypes. *, p< 0.05; **, p< 0.01; ***, p< 0.001. (E): ACh
responses of ependymal cells and CSFcCs in the presence of DHbE (1 mM) alone or with DHbE and PNU 120596 (10 mM). In the bottom
trace, the ACh responses were also tested in the presence of DHbE, PNU 120596, and a7*nAChR antagonist methyllycaconitine (MLA)
(20 nM). The bar chart shows the mean data for the effects of PNU 120596 in the presence of DHbE and MLA. Abbreviations: ACh, acetyl-
choline; CSFcC, cerebrospinal ﬂuid contacting cell; DHbE, dihydro-b-erythroidinne; MCA, mecamylamine; MLA, methyllycaconitine.
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analyzed from thoracic and lumbar spinal cord regions and
the locations of EdU-positive cells were mapped (Fig. 5).
In the CC area (Fig. 5E), the average numbers of EdU-
positive cells per section in control animals (N5 4 animals)
injected with saline were 1.06 0.2, (n5 35 sections) in the
thoracic region and 1.46 0.3 (n5 40 sections) in the lumbar
region. In comparison with control sections, injection of PNU
120596 signiﬁcantly increased (p< 0.0001) the average num-
ber of EdU-labeled cells per section in the CC area in both
the thoracic (3.06 0.2, n5 40 sections, N5 4 animals) and
lumbar (4.66 0.4, n5 40 sections) regions.
In the grey matter (Fig. 5F), not including the CC region
already counted, the average numbers of EdU-labeled cells
per section in control animals were 11.96 1.2 (n5 35 sec-
tions) in thoracic sections and 15.26 0.8 (n5 40 sections) in
lumbar sections. Injection of PNU 120596 caused a signiﬁcant
(p< 0.0001) increase in the number of EdU-labeled cells in
the grey matter of both the thoracic (15.96 1.3 cells per sec-
tion, n5 40 sections) and lumbar (21.86 1.3 cells per section,
n5 40 sections) spinal cord compared with control. In the
white matter, (Fig. 5F) control animals had EdU-labeled cells
in both the thoracic (30.66 2.0 cells per section, n5 35 sec-
tions) and lumbar (37.86 2.7 cell per section, n5 40 sections)
regions. Once again, injection of PNU 120596 caused a signiﬁ-
cant (p< 0.0001) increase in EdU-labeled cells in the white
matter of thoracic (42.36 2.0 cells per section, n5 40 sec-
tions) and lumbar (49.56 1.9 cells per section, n5 40 sec-
tions) regions.
Identity of Proliferating Cells in the CC
As both CSFcCs and ependymal cells were shown to be acutely
depolarized by activation of a7*nAChRs, we next established
which type of cells were proliferating in both cultured slices
and in vivo. Using antibodies for CD24 or NKAa1 [22] as markers
for ependymal cells and PKD2L1 as a marker of CSFcCs, dual
labeling for EdU was carried out on treated slices. Colocalization
of anti-PKD2L1 and EdU labeling was not observed in either
condition (n5 13 slices, N5 6 animals for cultured slices; Fig.
4C and n5 15 sections, N5 5 animals for in vivo treatment;
Fig. 6A); however, colocalization of anti-CD24 or NKAa1 and
EdU labeling was always seen in both cultured slices and after
in vivo treatment (n5 13 slices, N5 6 animals for cultured sli-
ces; Fig. 4Ci–4E and n5 16 sections, N5 5 animals for in vivo
treatment; Fig. 6B, 6C). Furthermore, EdU in the ependymal
layer always colocalized with Sox2, a transcription factor associ-
ated with ependymal cells [23], in both the in vivo experiments
(Fig. 6D) and cultured spinal cord slices. Taken together, the
presence of Sox2 in the nucleus and CD24 and NKAa1 in the
membranes surrounding all EdU-positive cells, is consistent
with activation of a7*nAChRs selectively initiating proliferation
in ependymal cells and not CSFcCs.
The identity of those cells in the CC that had proliferated in
vivo was further tested using dual labeling techniques after in
vivo treatment with PNU 120596. EdU-labeled cells surrounding
the CC contained immunoreactivity for the transcription factor
Sox2, consistent with a stem cell identity ([24]; Fig. 6D). Fur-
thermore, EdU-labeled cells did not contain immunoreactivity
for class III ß tubulin (Tuj1) a marker for immature and mature
neurons ([25]; Fig. 6E), the reactive glial cell marker GFAP ([26];
Fig. 6F) or the oligodendrocyte marker PanQKI ([27, 28]; Fig.
6G). There were never any neuronal nuclei marker (NeuN)
Figure 4. Administration of the selective a7*nAChR modulator,
PNU 120596 increased proliferation of ependymal cells in spinal
cord cultures. (A): The numbers of 5-ethynyl-2’-deoxyuridine
(EdU)-positive cells per 300 mm slice in the presence of saline
alone, PNU 120596 (1 mM) alone, PNU 120596, and the a7*nAChR
antagonist methyllycaconitine (MLA) (20 nM) or MLA (20 nM)
alone. (B): Confocal images showing examples of EdU-labeled cells
in animals treated with saline, PNU 120596 (Bi) or PNU 120596
and MLA (Bii). (C–Cii): confocal images showing EdU-labeled cells
in the region of the central canal do not contain immunoreactivity
for the cerebrospinal ﬂuid contacting cell marker PKD2L1 (C) yet
are colocalized with immunoreactivity for the ependymal cell
markers NKA a1 (Ci) and CD24 (Cii) following treatment with PNU
120596. (D–Eii): Higher power confocal images showing EdU-
labeled cells (D, E) are also immunoreactive for NKA a1 (Di) and
CD24 (Ei) as shown by the merged images (Dii, Eii) following treat-
ment with PNU 120596. (F): EdU-labeled cells (F) colocalize with
PanQKI immunoreactivity (Fi, Fii). Scale bars5 20 mm. Abbrevia-
tions: EdU, 5-ethynyl-2’-deoxyuridine; MLA, methyllycaconitine.
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Figure 5. In vivo administration of the cholinergic modulator PNU 120596 increased the number of 5-ethynyl-2’-deoxyuridine (EdU)-
labeled cells in both thoracic and lumbar regions. (A–D): Representative diagrams showing the distribution of EdU-labeled cells in con-
trol sections in thoracic (A) and lumbar (B) regions compared with PNU 120596 treated sections at thoracic (C) and lumbar (D) levels.
(Ai–Di): Confocal images of the EdU-labeled cells surrounding the central canal (CC) from the representative diagrams above. Scale
bars5 20 mm. (E, F): Average number of EdU-labeled cells per 50 mm section6 SE in the area of the CC (E), grey and white matter (F)
of thoracic and lumbar spinal cord sections in control and PNU 120596 treated animals. ****, p< 0.0001. Abbreviation: EdU, 5-ethynyl-
2’-deoxyuridine.
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Figure 6. Following in vivo PNU 120596 administration, 5-ethynyl-2’-deoxyuridine (EdU)-labeled cells surrounding the central canal (CC)
are proliferating, yet undifferentiated. (A–D): Confocal images following PNU 120596 application in vivo showing EdU-labeled cells sur-
rounding the CC (Ai) are distinct from the population of PKD2L1 immunoreactive cerebrospinal ﬂuid contacting cells (Aii) as seen in the
merged image (Aiii). EdU-labeled cells (Bi, Ci) are colocalized with immunoreactivity for the ependymal cell markers CD24 (Bii) and NKA
a1 (Cii) as shown in the merged images (Biii, Ciii). EdU-labeled cells contain immunoreactivity for the transcription factor Sox2 (EdU
[Di], Sox2 [Dii], merged image [Diii]; boxed area shows a higher magniﬁcation of a dual-labeled cell). EdU-labeled cells show no colabel-
ing with the neuronal marker Tuj1 (Ei–Eiii), the astrocyte marker glial ﬁbrillary acidic protein (Fi–Fiii) or the oligodendrocyte marker Pan-
QKI (Gi–Giii). Scale bars5 10 mm. Abbreviations: EdU, 5-ethynyl-2’-deoxyuridine; GFAP, glial ﬁbrillary acidic protein; NKAa1, Na1/K1
ATPase a1.
immunopositive neurons (labeling mature neurons) in the vicin-
ity of the CC (not shown). The colocalization of EdU with Sox2,
CD24, and NKAa1 normally expressed by ependymal cells, but
not GFAP nor PKD2L1 which are expressed by other ependymal
layer cell types, is consistent with the EdU positive ependymal
layer cells being ependymal cells with stem cell characteristics.
As the newly proliferated cells in the CC region of the
intact spinal cord seem to be maintained in a state of readi-
ness as stem cells, we hypothesized that signals to induce dif-
ferentiation were absent and the a7nAChR activation could
be strongly promoting proliferation over differentiation. As
preparation of the spinal cord cultures necessarily involves
damage to the system again, we hypothesized this may be
sufﬁcient to trigger such differentiation. In control conditions,
cells in the CC were neither NeuN nor Tuj1 immunoreactive,
while the proportions of EdU-labeled cells that were also
labeled for GFAP (2.46 1.2 %) or PanQKI (7.36 2.4 %) were
quite low. PNU 120596 application resulted not only in an
increase in proliferation but also signiﬁcantly (p5 0.02)
increased the proportion of cells that were colabeled for Pan-
QKI to 15.16 2.6 % (Fig. 4F). There were still no cells cola-
beled for EdU and either NeuN or Tuj1 nor was there a
signiﬁcant change in the level of colabeling for EdU and GFAP
(4.06 1.0 %). This suggests that presence of an a7nAChR
potentiator results in the proliferating cells preferentially dif-
ferentiating along an oligodendrocyte lineage.
Identity of Proliferating Cells in the Other Spinal Cord
Regions
In the grey and white matter of the spinal cord, the numbers
of cells colocalized for EdU and either NeuN or GFAP were
negligible. These were not changed by the application of PNU
120596. However, there were moderately high percentages of
EdU immunoreactive cells that were also colabeled for PanQKI
in thoracic (grey matter 24.0%6 6.7%, white matter
21.8%6 3.4%) and lumbar (grey matter 12.9%6 3.3%, white
matter 17.4%6 2.2%) sections. These proportions were signiﬁ-
cantly (p5 0.0001) increased by PNU 120596 in both thoracic
(grey matter 51.1%6 5.3%, white matter 36.1%6 4.2%) and
lumbar (grey matter 34.6%6 5.7%, white matter
32.8%6 3.6%) sections (Fig. 7). This indicates that the newly
proliferated cells in the intact white and grey matter of the
spinal cord also preferentially express oligodendrocyte
markers.
DISCUSSION
This study provides the ﬁrst evidence that cell proliferation in
the neurogenic niche of the postnatal mammalian spinal cord
is signiﬁcantly enhanced by the potentiation of endogenous
ACh through activation of a7*nAChRs in both organotypic
slice cultures and in vivo. Although both ependymal cells and
CSFcCs of the mammalian spinal cord responded robustly to
ACh in acute spinal cord slices, our data revealed it was only
the ependymal cells that were capable of cholinergic receptor
induced proliferation. In addition, a7*nAChR stimulation
resulted in proliferation of cells in both the white and grey
matter. There was a signiﬁcant increase in the proportion of
newly proliferated cells that expressed oligodendrocyte
markers.
Cholinergic Responses of Ependymal Cells and CSFcCs
The combination of immunohistochemistry demonstrating the
presence of cholinergic structures closely apposing ependymal
cells and CSFcCs and electrophysiology demonstrating mainte-
nance of the ACh response in TTX, suggests that the ACh
response is mediated by receptors located directly on the
membrane of both cell types. The cholinergic structures may
be either synaptic terminals or dendrites; in other central
nervous system (CNS) regions, both dendrites and axon termi-
nals have the capacity to release acetylcholine [29]. There
could be an alternative source of ACh or choline within the
CSF [30], which both cell types contact. The variation in the
size of the ACh response in different CSFcC subtypes is likely
to correspond to a difference in receptor density or propor-
tions of receptors mediating the response.
Both antagonisms of the cholinergic response by DHbE and
potentiation of the response by PNU 120596 are in agreement
with in situ hybridization studies, which reveal the expression
of a7*nAChR [31] and non-a7*nAChR subunits including a2–4
and b2 [32]. In addition, an a7 nAChR subunit reporter mouse
made by the Gensat project (Gensat 2012) showed some GFP
expressing CSFcCs. As DHbE is a preferential antagonist at
a4*nAChRs and b2*nAChRs [33, 34], it is likely that
a4b2*nAChRs could be contributing to the cholinergic response
in both ependymal cells and CSFcCs, however, this needs fur-
ther conﬁrmation. The indication of the presence of a7*nAChRs
was further supported by the antagonism of PNU 120596
potentiation by MLA in both acute and cultured slices.
Functional Implications of Cholinergic Modulation of
Cells in the Neurogenic Niche
The importance of this cholinergic inﬂuence on the CC neuro-
genic niche is maintained into adulthood since it was observed
in both cultured slices obtained from juvenile animals and fully
mature mice, using the in vivo preparation. The higher number
of proliferating cells in the control cultured spinal cord slices
compared with the in vivo situation is likely due to the fact that
slice culture is more representative of an injury state in which
increased proliferation is observed [4, 5]. This further indicates
that cholinergic enhancement of proliferation can occur in
physiological and pathological situations. Indeed, the reduction
of proliferation by application of only a7*nAChR antagonists in
culture suggests that these receptors may be necessary and suf-
ﬁcient for injury induced proliferation to occur.
There are a number of functional implications to consider
with regards to the effects of the cholinergic modulators on
ependymal cells and CSFcCs. The fact that PNU 120596 has an
effect in cultured slices suggests that the source of ACh is local
and maintained in this reduced preparation. An initial consider-
ation is whether the two possible sources of ACh, axodendritic,
or CSF, are mediating different functional effects. For example,
structures containing ACh closely apposing both cell types could
be important for ensuring that newly generated cells are inte-
grated within the spinal cord circuitry, responding to neighbor-
ing cells and contributing to speciﬁc pathways. This idea is
similar to that recently proposed in the subventricular zone
where newly identiﬁed cholinergic neurons are sufﬁcient to
control neurogenic proliferation [15]. In the case of CSFcCs, it
has previously been hypothesized that these cells act as sensory
neurons, sensing the composition of the CSF [35], and this is
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supported as they can respond to changes in pH and ATP [7].
This study, however, provides evidence that they are far more
complex than simple CSF sensors; they could be modulated by
other neurons. The origin of the cholinergic structures inﬂuenc-
ing either ependymal cells or CSFcCs is currently unknown,
although it could be speculated that they are from partition or
CC cluster cholinergic interneurons located in lamina X [36].
One possible source is a small cluster of cholinergic interneur-
ons in the CC region that provide c boutons onto motoneurons
[16]; their close proximity to the ependymal cell layer would
enable release from either dendrites or axon terminals. Given
the central location of ependymal cells and CSFcCs within the
spinal cord, they are well placed to receive inputs regarding
sensory, autonomic and motor functions. Alternatively or
indeed additionally, ACh or choline within the CSF [37] could
act in a paracrine manner coordinating a widespread effect on
Figure 7. Following in vivo PNU 120596 administration, 5-ethynyl-2’-deoxyuridine (EdU)-labeled cells in the white and grey matter prefer-
entially become oligodendrocytes. (A) Average percentage6 SE of 5-ethynyl-2’-deoxyuridine (EdU) and PanQKI colabeled cells per 50 mm
section in the grey matter (gm) and white matter (wm) of thoracic and lumbar spinal cord sections in control and PNU 120596-treated ani-
mals. *, p< 0.05; **, p< 0.01; ***, p< 0.001. (B, C): Confocal images showing examples of EdU and PanQKI-IR colocalization in grey (Bi–
Biii) and white (Ci–Ciii) matter. Scale bars5 20 mm. Abbreviations: EdU, 5-ethynyl-2’-deoxyuridine; PNU, PNU 120596; WM, white matter.
2874 Cholinergic Effects on the Spinal Neurogenic Niche
VC 2015 The Authors STEM CELLS published by STEM CELLS
Wiley Periodicals, Inc. on behalf of AlphaMed Press
populations of ependymal cells and CSFcCs throughout the spi-
nal cord. This is less likely due to the fact that MLA reduced pro-
liferation in the culture, where CSF is washed out.
Both sources of ACh could mediate effects on the prolifer-
ation, maturation, and survival of both cell types. With regard
to CSFcCs, our study did not reveal a7*nAChR mediated pro-
liferation of CSFcCs, although these cells were highly respon-
sive to activation of these receptors. It is also possible that
cholinergic receptor activation of CSFcCs or indeed other
intermediary cells could release factors which in turn contrib-
ute to the ependymal cell proliferation. However, our evi-
dence from the recordings in acute spinal cord slices suggests
that proliferation of ependymal cells could be due to a direct
activation of cholinergic receptors on these cells. Cholinergic
stimulation of ependymal cells is likely to induce an increase
in intracellular Ca21, as observed in other non-neuronal CNS
cells [38, 39], leading to a number of downstream effects.
Interestingly, following increases in intracellular Ca21, the
coupled nature of ependymal cells would enable propagation
of Ca21 waves as observed in radial glial cells during embry-
onic neurogenesis and neural progenitor cells in the postnatal
subventricular zone [40, 41]. Ependymal cells of the spinal
cord proliferate to maintain the ependymal cell population
under normal conditions [2]. This study demonstrates that
cholinergic modulation enhances this proliferation and as this
system is readily accessed pharmacologically, this provides an
avenue for therapeutic intervention.
Implications for New Avenues in Spinal Cord
Regeneration
An important ﬁnding in the CC was the strong colocalization
of EdU with the transcription factor Sox2. Sox2 is considered
a marker of neural stem cells since it inhibits neuronal differ-
entiation and maintains progenitor characteristics [24], which
is also evident in the spinal cord ependymal cell population
[42]. Thus, enhancing the actions of a7*nAChRs leads to
increased production of neural stem cells. We did not ﬁnd evi-
dence of differentiation of the newly proliferated cells in the
intact CC region of spinal cord since EdU was not colocalized
with markers of neurons or glial cells, but our short recovery
period is likely to have precluded this. Alternatively, signals
for appropriate differentiation may have been absent in the
CC of spinal cords. However, in the cultured spinal cord slices,
we found that a higher proportion of the EdU positive CC
cells was also colabeled with anti-PanQKI in PNU 120596
treated animals compared with control. This suggests that in
this spinal cord slice culture, differentiation along the oligo-
dendrocyte lineage is more prominent when a7*nAChRs are
activated. In fact, it is known that mammalian spinal ependy-
mal cells can differentiate in some conditions, indeed they
are the only spinal cells capable of generating progeny of
multiple fates [5]. In a mouse model of multiple sclerosis,
ependymal cells not only proliferated but also migrated and
differentiated into neurons [6]. A recent study in zebraﬁsh
was the ﬁrst to demonstrate that a neurotransmitter (dopa-
mine) could promote spinal motor neuron generation in the
lesioned spinal cord [9]. Therefore, similar to other CNS
regions [43], identiﬁcation of appropriate signals to direct dif-
ferentiation and improve survival and integration of endoge-
nously produced neural precursors will be amongst the next
steps towards spinal repair.
Another important ﬁnding was the increased number of
EdU-labeled cells in the white and grey matter of the spinal
cord following PNU 120596 administration. These cells also
expressed Sox2, indicating the potential to increase stem cell
production outside of the CC. Indeed, PNU treatment not
only increased EdU labeling, but resulted in an increased pro-
portion of EdU-labeled cells being immunoreactive for PanQKI.
While the identity of the cells contributing to the a7*nAChR
induced proliferation in the white and grey matter remains to
be determined, one potential source could be the meninges
[44]. It is clear though that the a7*nAChR could be a viable
target to increase the numbers of oligodendrocytes in the spi-
nal cord, perhaps following injury or in demyelinating diseases
such as multiple sclerosis.
SUMMARY
In conclusion, this study is the ﬁrst to demonstrate that neu-
rotransmitter mediated manipulation can enhance spinal cord
cell proliferation in mammals. One likely source of these cells
is the ependymal cell layer [4, 5], consistent with our observa-
tions here. The factors determining the fates of these cells
require further elucidation, but our data provide new poten-
tial for future therapeutic interventions since the cholinergic
system can be manipulated by drugs that cross the blood
brain barrier.
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